Trial Profile
A phase III randomised comparison of gemcitabine/carboplatin with cisplatin in small cell lung cancer.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Nov 2021
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Carboplatin; Cisplatin; Etoposide; Etoposide
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 13 May 2009 Additional lead trial investigator Rudd R identified as reported by United Kingdom Clinical Research Network record.
- 13 May 2009 New source identified and integrated (United Kingdom Clinical Research Network).
- 16 Feb 2006 New trial record.